Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PPM1B | O75688 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197068 | 0.87 | ALDH1A1 (0.50) | NAAADGKAALDH1A1HCAR2LMNA | |
| SCHEMBL18938296 | 0.85 | HTT (0.37) | NAAADGKATDP1 | |
| SCHEMBL9937456 | 0.85 | NAAA (0.59) | NAAADGKAALDH1A1HCAR2CES2 | |
| SCHEMBL18927364 | 0.84 | NAAA (0.47) | NAAADGKAALDH1A1TSHRDNM1 | |
| SCHEMBL28633532 | 0.83 | NAAA (0.36) | NAAADGKAALDH1A1HCAR2LMNA | |
| SCHEMBL974467 | 0.81 | GAA (0.52) | ALDH1A1LMNARAB9A | |
| SCHEMBL18938210 | 0.81 | NAAA (0.41) | NAAADGKAALDH1A1CES2TSHR | |
| SCHEMBL18927365 | 0.81 | NAAA (0.59) | NAAADGKAALDH1A1CES2RAD52 | |
| SCHEMBL9937991 | 0.81 | ALDH1A1 (0.52) | NAAADGKAALDH1A1CES2TSHR | |
| SCHEMBL9936620 | 0.80 | TSHR (0.38) | DGKAALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250364602-A1 | ELECTROLYTE SOLUTION, SECONDARY BATTERY AND ELECTRICAL APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2025-11-27 | — | — | US | claimed |
| EP-4621914-A1 | ELECTROLYTE, SECONDARY BATTERY, AND ELECTRIC DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2025-09-24 | — | — | EP | claimed |
| WO-2025039578-A1 | ELECTROLYTE, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2025-02-27 | — | — | WO | claimed |
| CN-114388746-B | Lithium metal negative electrode, lithium metal battery, preparation method of lithium metal negative electrode and lithium dendrite inhibition method | 安徽盟维新能源科技有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-115810799-A | High-performance lithium metal battery electrolyte and high-performance lithium metal battery | 安徽盟维新能源科技有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-114388746-A | Lithium metal negative electrode, lithium metal battery, preparation method of lithium metal negative electrode and lithium metal battery and method for inhibiting lithium dendrite | 安徽盟维新能源科技有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-122025824-A | Electrolyte, secondary battery, and electricity-using device | 蜂巢能源科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250364602-A1 | ELECTROLYTE SOLUTION, SECONDARY BATTERY AND ELECTRICAL APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2025-11-27 | — | — | US | disclosed |
| EP-4621914-A1 | ELECTROLYTE, SECONDARY BATTERY, AND ELECTRIC DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2025-09-24 | — | — | EP | disclosed |
| WO-2025039578-A1 | ELECTROLYTE, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2025-02-27 | — | — | WO | disclosed |
| CN-114388746-B | Lithium metal negative electrode, lithium metal battery, preparation method of lithium metal negative electrode and lithium dendrite inhibition method | 安徽盟维新能源科技有限公司 | 2024-01-23 | — | — | CN | disclosed |
| US-20230350294-A1 | Negative Photosensitive Resin Composition, Patterning Process, Interlayer Insulating Film, Surface Protection Film, And Electronic Component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11768434-B2 | Polymer having a structure of polyamide, polyamide-imide, or polyimide, photosensitive resin composition, patterning process, photosensitive dry film, and protective film for electric and electronic parts | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-26 | — | — | US | disclosed |
| US-20120130090-A1 | TRIFLUOROMETHYLTHIOPHENIUM DERIVATIVE SALT, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING TRIFLUOROMETHYL-CONTAINING COMPOUNDS USING THE SAME | TOSOH F-TECH, INC. (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120059163-A1 | Non-linear opticaly active molecules, their synthesis, and use | OPTIMER PHOTONICS, INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-20080004415-A1 | Non-linear optically active molecules, their synthesis, and use | OPTIMER PHOTONICS, INC. (US) | 2008-01-03 | — | — | US | disclosed |
| US-4359404-A | Hydrogenation of esters using alkali doped heterogeneous Group VIII transition metal catalysts | ALLIED CORPORATION (US) | 1982-11-16 | — | — | US | disclosed |
| US-4346240-A | Hydrogenation of esters using alkali doped heterogeneous group VIII transition metal catalysts | ALLIED CORPORATION (US) | 1982-08-24 | — | — | US | disclosed |
| EP-0036939-A1 | Hydrogenation of esters using alkali doped heterogeneous group VIII transition metal catalysts | ALLIED CORPORATION (US) | 1981-10-07 | — | — | EP | disclosed |
| US-4232170-A | DECARBONYLATION, GROUP 8, METAL HYDRIDE COMPLEXES | ALLIED CHEMICAL CORPORATION (US) | 1980-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059163-A1 | Non-linear opticaly active molecules, their synthesis, and use | INCENP, CYBA, ADCY5 | NAAA 1044/4885DGKA 3074/4885ALDH1A1 371/4885 |
| US-20120130090-A1 | TRIFLUOROMETHYLTHIOPHENIUM DERIVATIVE SALT, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING TRIFLUOROMETHYL-CONTAINING COMPOUNDS USING THE SAME | TST, CBR3, CYP4B1 | NAAA 3015/4885DGKA 4817/4885ALDH1A1 3183/4885 |
| US-20080004415-A1 | Non-linear optically active molecules, their synthesis, and use | INCENP, CYBA, PAICS | NAAA 1024/4885DGKA 3281/4885ALDH1A1 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.